Literature DB >> 3262337

Human recombinant interleukin-1 regulates cellular mRNA levels of dermatan sulphate proteoglycan core protein.

J Heino1, V M Kähäri, A Mauviel, T Krusius.   

Abstract

Human skin fibroblasts were exposed to various concentrations (from 0.01 to 5.0 units/ml) of human recombinant interleukin-1 alpha and interleukin-1 beta (IL-1 alpha and IL-1 beta). Both IL-1 alpha and IL-1 beta were found to increase dermatan-sulphate-proteoglycan (DSPG) core-protein mRNA levels. Maximal increase (3.0-fold) was seen at 48 h after addition of 1 unit of IL-1 beta/ml. In spite of the elevated DSPG-core-protein mRNA only a slight increase (from 10 to 18%) could be seen in the production of DSPG to cell-culture medium. No changes in the molecular mass of DSPG could be detected.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3262337      PMCID: PMC1149141          DOI: 10.1042/bj2520309

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  22 in total

1.  Interleukin-1-like factor (mononuclear cell factor) modulates proteoglycan synthesis in cultured human synovial cells.

Authors:  M Langris; M Daireaux; V Jouis; J Bocquet; G Loyau
Journal:  Biochim Biophys Acta       Date:  1987-01-19

2.  Primary structure of an extracellular matrix proteoglycan core protein deduced from cloned cDNA.

Authors:  T Krusius; E Ruoslahti
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

3.  Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon.

Authors:  K G Vogel; M Paulsson; D Heinegård
Journal:  Biochem J       Date:  1984-11-01       Impact factor: 3.857

4.  Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs.

Authors:  C J March; B Mosley; A Larsen; D P Cerretti; G Braedt; V Price; S Gillis; C S Henney; S R Kronheim; K Grabstein
Journal:  Nature       Date:  1985 Jun 20-26       Impact factor: 49.962

5.  Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family.

Authors:  P Fort; L Marty; M Piechaczyk; S el Sabrouty; C Dani; P Jeanteur; J M Blanchard
Journal:  Nucleic Acids Res       Date:  1985-03-11       Impact factor: 16.971

6.  Nucleotide sequence of human monocyte interleukin 1 precursor cDNA.

Authors:  P E Auron; A C Webb; L J Rosenwasser; S F Mucci; A Rich; S M Wolff; C A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

7.  Interleukin 1 stimulation of synovial cell plasminogen activator production.

Authors:  E Mochan; J Uhl; R Newton
Journal:  J Rheumatol       Date:  1986-02       Impact factor: 4.666

8.  Specific bioactivities of monocyte-derived interleukin 1 alpha and interleukin 1 beta are similar to each other on cultured murine thymocytes and on cultured human connective tissue cells.

Authors:  E A Rupp; P M Cameron; C S Ranawat; J A Schmidt; E K Bayne
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

9.  Interleukin 1 enhances synovial cell hyaluronate synthesis.

Authors:  D Hamerman; D D Wood
Journal:  Proc Soc Exp Biol Med       Date:  1984-10

10.  Identification of a high-affinity receptor for native human interleukin 1 beta and interleukin 1 alpha on normal human lung fibroblasts.

Authors:  J Chin; P M Cameron; E Rupp; J A Schmidt
Journal:  J Exp Med       Date:  1987-01-01       Impact factor: 14.307

View more
  11 in total

1.  Leukoregulin down-regulates type I collagen mRNA levels and promoter activity in human dermal fibroblasts, and counteracts the up-regulation elicited by transforming growth factor-beta.

Authors:  A Mauviel; C H Evans; J Uitto
Journal:  Biochem J       Date:  1992-06-15       Impact factor: 3.857

2.  Macrophage secretory products selectively stimulate dermatan sulfate proteoglycan production in cultured arterial smooth muscle cells.

Authors:  I J Edwards; W D Wagner; R T Owens
Journal:  Am J Pathol       Date:  1990-03       Impact factor: 4.307

Review 3.  Small proteoglycans.

Authors:  H Kresse; H Hausser; E Schönherr
Journal:  Experientia       Date:  1993-05-15

4.  Interleukin-1 beta prevents the stimulatory effect of transforming growth factor-beta on collagen gene expression in human skin fibroblasts.

Authors:  J Heino; T Heinonen
Journal:  Biochem J       Date:  1990-11-01       Impact factor: 3.857

5.  Receptor-mediated endocytosis and nuclear transport of human interleukin 1 alpha.

Authors:  S Grenfell; N Smithers; K Miller; R Solari
Journal:  Biochem J       Date:  1989-12-15       Impact factor: 3.857

6.  Activation of extracellular signal-regulated protein kinase1,2 results in down-regulation of decorin expression in fibroblasts.

Authors:  P Laine; N Reunanen; L Ravanti; M Foschi; M Santra; R V Iozzo; V M Kähäri
Journal:  Biochem J       Date:  2000-07-01       Impact factor: 3.857

7.  Ca2+ responses to interleukin 1 and tumor necrosis factor in cultured human skin fibroblasts. Possible implications for Reye syndrome.

Authors:  B E Corkey; J F Geschwind; J T Deeney; D E Hale; S D Douglas; L Kilpatrick
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

8.  Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries.

Authors:  R Riessen; J M Isner; E Blessing; C Loushin; S Nikol; T N Wight
Journal:  Am J Pathol       Date:  1994-05       Impact factor: 4.307

9.  Differences in decorin expression by papillary and reticular fibroblasts in vivo and in vitro.

Authors:  E Schönherr; L A Beavan; H Hausser; H Kresse; L A Culp
Journal:  Biochem J       Date:  1993-03-15       Impact factor: 3.857

10.  Interleukin-1 beta regulation of fibroblast proteoglycan synthesis involves a decrease in versican steady-state mRNA levels.

Authors:  E E Qwarnström; H T Järveläinen; M G Kinsella; C O Ostberg; L J Sandell; R C Page; T N Wight
Journal:  Biochem J       Date:  1993-09-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.